ADVFN US – Market Content Editor
-
MercadoLibre shares soar to a record $2,645.22 amid robust growth
MercadoLibre Inc. (NASDAQ:MELI), the leading e-commerce platform in Latin America, saw its stock climb to an all-time peak of $2,645.22, reflecting its dominant position in the region’s rapidly expanding digital economy. The company now boasts a market cap of $132.5 billion and maintains strong gross profit margins around 52%. Over the last 12 months, MercadoLibre’s…
-
Warner Bros. Discovery Shares Slide After $1B Stake Sale by Advance/Newhouse
Shares of Warner Bros. Discovery (NASDAQ:WBD) fell 4.9% on Tuesday, retreating from $11.46 to $10.90, after longtime stakeholder Advance/Newhouse offloaded a substantial portion of its holdings in the media giant. A regulatory filing revealed that affiliates of Advance/Newhouse—specifically ANPP Diversified and ANP—executed a block sale of 100 million common shares on June 30, 2025, at…
-
Planet Labs Stock Jumps After €240M Satellite Services Deal With German Government
Shares of Planet Labs (NYSE:PL) surged 18% after the company announced a major €240 million multi-year agreement with the German government, marking a significant step forward in its defense and security business. The Earth imaging firm will deliver satellite-based services focused on European peace and security starting in January 2026. The deal includes dedicated use…
-
Sonim Technologies Shares Sink After Discounted Public Offering Announcement
Shares of Sonim Technologies Inc. (NASDAQ:SONM) fell sharply on Monday, plunging 36% following news that the company is conducting a public offering at a price well below its previous market value. The provider of rugged mobile devices priced an offering of 7.4 million shares at $0.75 each, a steep discount that values the gross proceeds…
-
IGM Biosciences Shares Surge on Takeover Agreement with Concentra
IGM Biosciences Inc. (NASDAQ:IGMS) saw its stock jump 20% after revealing it has reached a definitive agreement to be acquired by Concentra Biosciences in a cash-and-contingent deal. According to the terms announced, Concentra will purchase IGM Biosciences for $1.247 per share in cash, along with a non-tradeable contingent value right (CVR) for each share. The…
-
New Era Helium Shares Jump on AI Data Center JV’s Cloud Deal Plans
Shares of New Era Helium Inc. (NASDAQ:NEHC) surged 20% following the announcement that its joint venture with Sharon AI, known as Texas Critical Data Centers LLC (TCDC), has signed a non-binding Letter of Intent (LOI) with a top-tier global cloud services provider focused on artificial intelligence workloads. The agreement outlines potential collaboration on a large-scale…
-
Vivos Therapeutics Shares Skyrocket After Medicare Greenlights VidaSleep Oral Device
Vivos Therapeutics Inc. (NASDAQ:VVOS) saw its stock soar by 90% following a major regulatory win: the company’s VidaSleep oral appliance has secured approval from the Centers for Medicare & Medicaid Services (CMS) for the treatment of obstructive sleep apnea (OSA) and adult snoring. The approval comes from CMS’s Pricing, Data Analysis, and Coding (PDAC) contractor,…
-
Flux Power Stock Jumps After $2M+ Battery Deal With Major Airline
Shares of Flux Power Holdings Inc. (NASDAQ:FLUX) climbed 11% on Tuesday following the company’s announcement of a major new order from a prominent U.S. airline. The $2 million+ purchase covers 120 of Flux’s recently updated G80-420 lithium-ion battery packs, which will be delivered throughout 2025. The batteries are slated for use in airport ground support…
-
ATAI Life Sciences Shares Soar Following Strong Phase 2b Results for Depression Treatment
Shares of ATAI Life Sciences (NASDAQ:ATAI) skyrocketed 29% on Tuesday after the biotech company and its partner, Beckley Psytech, reported encouraging topline results from a Phase 2b trial evaluating their investigational depression treatment BPL-003 in patients with treatment-resistant depression. The clinical trial successfully met its primary endpoint along with all key secondary measures. Both the…
-
Adagene Shares Climb on Strengthened Collaboration and $25M Investment from Sanofi
Adagene Inc. (NASDAQ:ADAG) saw its shares rise by 6.1% on Tuesday after the biotech firm revealed a strategic investment deal with French pharmaceutical giant Sanofi (EPA:SASY) worth up to $25 million, further deepening their existing partnership. The new capital will support Adagene’s ongoing research and development efforts, with a particular focus on advancing clinical trials…